PillRx only · Kit
Levonorgestrel/Ethinyl Estradiol And Ethinyl Estradiol
Brands: Camrese · Jaimiess · Lojaimiess · Rivelsa +1
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.459
Latest avg · Jul 22, 2026
+197%
Since Dec 17, 2025
3
Active US suppliers
83%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.9K
Rx · 2026 Q1
266K
Units dispensed
-50%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | unknown | 3 | SUPPLYING |
| Xiromed, LLC. | unknown | 2 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 14, 2013RECALLRecall (Class III): Camrese(TM) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg and Ethinyl Estradiol 0.01 Tablets, 2 Extended-…
Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide